I've been fortunate to be this young woman's cardiologist for years. A moving story about lifelong challenges of #HCM, and how the @SpectrumHealth HCM, HF, bariatric & heart transplant teams (and @4hcm) worked together for this outcome. @SHHealthBeat https://t.co/wVX1snIIkp

#FunctionNotFailure. 💜🫀 Even @EricTopol agrees. @JCardFail EdPage 2021 @robmentz

The frequently used medical term "heart failure" is awful and needs to be replaced @NEJM @otago https://t.co/APO8QESeBf

"Uncommon Will, Far Better World," a $4 billion campaign to drive transformation at @michiganstateu & beyond. With 3 key ambitions: activate talent, imagine synergies, and build futures. #spartanswill @MSUMD, @MSU_Medicine https://t.co/J3vFRTPCZB

Thank you to BAMF Health colleagues, my neighbors at Doug Meijer Medical Innovations Building in Grand Rapids, for an eye popping tour of their truly innovative & forward looking work in #theranostics! #SpartansWill

Mavacamten was associated with reductions in biomarkers of cardiac wall stress and injury, with no sustained reductions in LVEF observed in patients with HFpEF and LVEF of 60% or greater. https://t.co/5DrG0fHAqo

The 8th paper from the @iStopMM study was published in @BloodCancerJnl in 2022. This study examines serum free light chain (FLC) reference intervals in kidney disease. We propose new eGFR-based reference intervals to improve accuracy. 📜📷#iStopMM #MGUS

Interesting 🐀 model study utilizing cardiac myosin inhibitors (mavacamten and aficamten) to reduce infarct size in ischemia-reperfusion, when cardiomyocytes become hypercontractile➡️contraction band necrosis. Future indications beyond #HCM/#HFpEF? 🫀 https://t.co/D5TQeZ5NrP

Excited to share ⁦@MayoClinic⁩ experience with #amyloid and🫀transplant 📌 Post tx survival #amyloid = non-amyloid pts 📌 ⬇️ wait times for #amyloid after allocation change 📌 ⬇️ multi- organ tx with TTR targeted therapies ⁦⁦@MayoAmyloid⁩

#CircAHA24 VALOR-HCM demonstrates sufficient and sustained long-term improvement in obstructive HCM patients to avoid septal reduction therapy. @DesaiMilindY @neallakdawala @AWangDukeU @tikuowens @S2beri @DavidFerminMD https://t.co/S2ApQES7vS

Join us tomorrow - virtual link below. An excellent meeting organized by @MicheleEmdin et al in Pisa https://t.co/mLWmZig2S5 #CardioTwitter #Amyloidosis

Doctor, I feel exhausted ❗️ Answer: 🫀 your engine is to small. #Exercise 🏃‍♂️ 🌟#StephRowe 🌟 showed that small left ventricular size predicts low VO2, performing even better than LAVi! optimal cut-off 88ml LVEDV 🤔Exercise deficiency syndrome

According to @thinkcollegeICI, 2% of students with intellectual disabilities are likely to attend college. But thanks to @SyracuseU's InclusiveU program, our students earn degrees and launch their careers. Discover InclusiveU's profound impact! #Podcast 🎧 https://t.co/KJqwBbPrhn

Robust research strategic planning @FM_HVI @CorewellHealth @MSU_Medicine discussions with @RenzoLoyaga @DavidFerminMD @wohnsmd #tomasztimek @AshMansour5 @chaz_hong and many others

💙 Our Hutch Hero @aidanhutch97 💙 @Lions Hutch has shared words of encouragement with these #LittleVictors and written many of their names on his water jug before each game. Now, they are sharing words of encouragement with him.

It is an absolute privilege to provide cardiovascular care for patients living with neuromuscular disorders, collaborate with neurology colleagues, and innovate solutions in the lab! @UMN_DCVM @umn_dom @UMNMDCenter @MDAorg #LGMDday2024

Why are all ECMO trials negative? We see several reasons: 1. VA ECMO is a rescue treatment which can make a difference between life and death 2. VA ECMO has serious complications, which also can make a difference between life and death 3. In proactive trial design, like in

Expanding our cardiac hospitalist program @FM_HVI for HF. Rounding as 1⃣team. Mentorship+collaboration. Streamlined care. Alignment in Rx plans with direct communication. Engagement of hospitalists/primary health needed to Rx HF. @DavidFerminMD +AHFTC team @EiranGorodeski @HFSA

Despite the hype, I'm not there on generative AI. -- I have seen very few meaningful use cases. -- The environmental impact is enormous/terrible. -- I'm totally drowning in AI-generated content and I'm worried we're going to forget how to write/ think. Sorry. I know I'm not